MARKET

ALBT

ALBT

Avalon Globocare Corp
NASDAQ
0.2466
-0.0096
-3.75%
After Hours: 0.2415 -0.0051 -2.07% 16:00 05/03 EDT
OPEN
0.2675
PREV CLOSE
0.2562
HIGH
0.2675
LOW
0.2412
VOLUME
30.95K
TURNOVER
0
52 WEEK HIGH
2.419
52 WEEK LOW
0.2412
MARKET CAP
2.74M
P/E (TTM)
-0.1554
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ALBT last week (0422-0426)?
Weekly Report · 5d ago
Weekly Report: what happened at ALBT last week (0415-0419)?
Weekly Report · 04/22 11:43
ALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023
Avalon Globocare reported results for the fourth quarter of 2023. The company reported earnings per share of -90 cents and revenue of $321,321. The company is a provider of medical equipment and supplies to the military and other industries.
Investorplace · 04/16 13:52
Financial Report of [Company Name] for the Fiscal Year Ended December 31, 2023
Press release · 04/16 00:13
Weekly Report: what happened at ALBT last week (0408-0412)?
Weekly Report · 04/15 11:34
Weekly Report: what happened at ALBT last week (0401-0405)?
Weekly Report · 04/08 11:39
AVALON GLOBOCARE - EXPECTS TO REPORT MATERIAL WEAKNESS IN ITS INTERNAL CONTROLS OVER FINANCIAL REPORTING AND ITS DISCLOSURE CONTROLS AND PROCEDURES
Reuters · 04/01 20:36
AVALON GLOBOCARE: UNABLE TO FILE, WITHOUT UNREASONABLE EFFORT OR EXPENSE, ANNUAL REPORT ON FORM 10-K FOR YEAR END DEC 31, 2023 BY PRESCRIBED DUE DATE
Reuters · 04/01 20:36
More
About ALBT
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

Webull offers Avalon Globocare Corp stock information, including NASDAQ: ALBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALBT stock methods without spending real money on the virtual paper trading platform.